Browsing Fysisk institutt by Author "Kolstad, Arne"

Now showing items 1-2 of 2

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma

Løndalen, Ayca; Blakkisrud, Johan; Rootwelt-Revheim, Mona-Elisabeth; Madsbu, Ulf Erik; Dahle, Jostein; Kolstad, Arne; Stokke, Caroline (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2020)

Purpose 177Lu-lilotomab satetraxetan targets the CD37 antigen and has been investigated in a first-in-human phase 1/2a study for relapsed non-Hodgkin lymphoma (NHL). Tumor dosimetry and response evaluation can be ...
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients

Stokke, Caroline; Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Holte, Harald; Kolstad, Arne (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)

Purpose: 177Lu-lilotomab satetraxetan is a novel anti-CD37 antibody radionuclide conjugate for the treatment of non-Hodgkin lymphoma (NHL). Four arms with different combinations of pre-dosing and pre-treatment have been ...

Browse